Yan Wang

Company: Allorion Therapeutics

Job title: Senior Medical Director - Clinical Development

Seminars:

Optimizing the Novel Multiplexing Biomarker Paradigm to Support Clinical Studies 11:35 am

Introduction of special based novel multiplexing paradigm to evaluate tumor and tumor microenvironment (apply both RNA and protein expression on one tissue slide if data available)  Optimization of the testing panel including the multiplexing assay procedure and result assessment  Selection of the multiplex paradigm to best support clinical studiesRead more

day: Day Three Track A